Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Stephan Grupp, MD, PhD, of the Children’s Hospital of Philadelphia, Philadelphia, PA, speaking from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, discusses the use of flow cytometry and NGS testing for determining MRD negativity in patients with acute lymphoblastic leukemia (ALL).
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.